Clinical

Dataset Information

0

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer


ABSTRACT: The purpose of this study is to determine whether CPX-1 is effective in patients with advanced colorectal cancer who have already received chemotherapy that included the drug oxaliplatin or irinotecan. All patients will receive CPX-1 at a dose of 210 units/m2 over 90 minutes every two weeks.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2031592 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| PRJNA99065 | ENA
2017-09-22 | GSE104108 | GEO
| phs000832 | dbGaP
| 2640889 | ecrin-mdr-crc
2016-08-19 | E-GEOD-79977 | biostudies-arrayexpress
2010-01-11 | GSE17796 | GEO
2011-04-29 | E-MEXP-3032 | biostudies-arrayexpress
2007-09-30 | GSE9072 | GEO
| PRJNA376598 | ENA
2019-09-26 | GSE116667 | GEO